Patheon to Present Multiple Scientific Findings at AAPS Annual Meeting and Exposition

Dr. Anil Kane will lead Patheon scientific team in nearly 20 presentations.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) November 07, 2013

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will have more than 16 posters and several presentations at the AAPS Annual Meeting and Exposition taking place in San Antonio, Texas, November 10-14, 2013.

Dr. Kane will be making a presentation to the Recent Advances in Fixed-Dose Combination Therapy Symposium. Director of Global Technical Affairs, Dr. Stephen Closs will be making a presentation at the From Particle Engineering to Powder Processing Symposium. In addition, other top scientists from Patheon will be presenting 16 scientific posters. According to Dr. Kane, “Patheon is pleased to share our scientific experience and demonstrate our expertise across areas as diverse as particle engineering, material properties and techniques for solubility enhancement, roller compaction and tableting, taste masking, multiparticulates, softgels and fixed dose combinations.”

A complete listing of all posters Patheon will be presenting at AAPS can be read below and by visiting http://www.patheon.com/marketing/AAPS2013_schedule/index.html.

Multiparticulate Based Drug Delivery to Achieve Zero Order Release
by Abhijit Gokhale, Thomas Williams and Jason Vaughn

Protection of Gelatin Capsule from Cracking through Environmental Relative Humidity Control
by Haibo Wang, Edgar Jaynes, Jeff Moore, Jason Vaughn and Chris Howell

Taste Masking and Solubility Enhancement of an Orally Disintegrating Tablet Containing a Hydrophobic Drug by Inclusion Complex Technique
by Arasu Kondappan, Venkata S. Rao Voleti, Don Barbieri and Jason Vaughn

Predictive Analytical Techniques to Assess Physical Stability of Liposome Based Formulations
by Enrico Corona

Effect of Die Hardness on Compression Tooling Performance to Produce Quality Tablets During High Speed Compression
by Vikram Senjalia and Francois Berthier

An Evaluation of the Capabilities of Liquid Chromatography – Diode Array Detection (LC-DAD) and Liquid Chromatography – Mass Spectrometry (LC-MS) to Detect Co-eluting Related Compound in Pharmaceutical Samples
by Geoff Carr, John Wang, Bharat Joshi, Senaka Ranaweera and Heng Yao

Knowledge Space Transfer using Small Scale Process Design to Facilitate Commercialization of a Roller Compaction Process
by Catarina Terra and Stephen Closs

Formulation Strategies to Optimize Performance of a Poorly Soluble Drug to Achieve Enhanced Solubility with Modified Release Properties
by Saujanya Gosangari, Tatyana Dyakonov and Rishi Thakur

Formulation and Evaluation of Self Micro Emulsifying Progesterone Dosage Forms for Vaginal Delivery
by Sunil Agnihotri, George Vamvakas and Tatyana Dyakonov

Progesterone Stability in Human Hepatocytes
by Peijin Zhang and Aqeel Fatmi

Fill Compositions for Extended Release Softgel Capsules
by Yunhua Hu

Assay and Identification of Mebeverine HCI Contained in a Formulation with Simethicone in Softgels by Liquid Chromatography
by Eduardo Rodrigues and Edith Ortega

Impact in the Rheological Stability of a Formulation in Soft Gelatin Capsule Containing Paracetamol (500 mg) and Hyoscine Butylbromide (10 mg) by Modifying the Kind of Suspensor Agent
by Marisol Martinez

About AAPS
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific association of approximately 11,000 members employed in industry, academia, government, and other research institutes worldwide. The AAPS Annual Meeting and Exhibition is a dynamic international forum where scientists, the media and the public can increase their understanding of the issues, advancements and opportunities facing public health today. For more information visit http://www.AAPS.org.

About Patheon
Patheon Inc. (TSX: PTI) is a leading provider of high-quality contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid, sterile and softgel dosage forms. The company serves approximately 300 of the world’s leading pharmaceutical and biotechnology companies through an integrated network of 12 commercial manufacturing facilities and 9 product development centers across North America and Europe. Patheon enables customers to launch products with confidence anywhere in the world. For more information visit http://www.patheon.com.